Distinct segregation of the pathogenic m.5667G>A mitochondrial tRNAAsn mutation in extraocular and skeletal muscle in chronic progressive external ophthalmoplegia

• Published in: Neuromuscular disorders : NMD Vol. 29; no. 5; pp. 358 - 367
• Main Authors: Schlapakow, Elena, Peeva, Viktoriya, Zsurka, Gábor, Jeub, Monika, Wabbels, Bettina, Kornblum, Cornelia, Kunz, Wolfram S.
• Format: Journal Article
• Language: English
• Published: Elsevier B.V 01.05.2019
• Subjects: Chronic progressive external ophthalmoplegia (CPEO); Heteroplasmy; mt-tRNAAsn; mtDNA copy number; Single muscle fiber; Single muscle fiber; mt-tRNAAsn; Chronic progressive external ophthalmoplegia (CPEO); Heteroplasmy; mtDNA copy number
• ISSN: 0960-8966; 1873-2364; 1873-2364
• DOI: 10.1016/j.nmd.2019.02.009

•The rare mitochondrial tRNA point mutation m.5667G>A is definitely pathogenic.•Higher proportions of COX-deficient fibers were observed in extraocular muscle (EOM).•This is very likely due to facilitated segregation of the mutation into EOM.•Our results can explain the preferential ocular manifestation and clinically isolated CPEO. Chronic progressive external ophthalmoplegia (CPEO) is a frequent clinical manifestation of disorders caused by pathogenic mitochondrial DNA mutations. However, for diagnostic purposes skeletal muscle tissue is used, since extraocular muscle tissue is usually not available for work-up. In the present study we aimed to identify causative factors that are responsible for extraocular muscle to be primarily affected in CPEO. We performed comparative histochemical and molecular genetic analyses of extraocular muscle and skeletal muscle single fibers in a case of isolated CPEO caused by the heteroplasmic m.5667G>A mutation in the mitochondrial tRNAAsn gene (MT-TN). Histochemical analyses revealed higher proportion of cytochrome c oxidase deficient fibers in extraocular muscle (41%) compared to skeletal muscle (10%). However, genetic analyses of single fibers revealed no significant difference either in the mutation loads between extraocular muscle and skeletal muscle cytochrome c oxidase deficient single fibers (extraocular muscle 86% ± 4.6%; skeletal muscle 87.8 %± 5.7%, p = 0.246) nor in the mutation threshold (extraocular muscle 74% ± 3%; skeletal muscle 74% ± 4%). We hypothesize that higher proportion of cytochrome c oxidase deficient fibers in extraocular muscle compared to skeletal muscle might be due to facilitated segregation of the m.5667G>A mutation into extraocular muscle, which may explain the preferential ocular manifestation and clinically isolated CPEO.